Olivier Coqueret

Title: Olivier Coqueret: Innovator in Breast Cancer Management

Introduction

Olivier Coqueret is a notable inventor based in Angers, France. He has made significant contributions to the field of breast cancer management through his innovative research and patented inventions. With a total of 3 patents, Coqueret's work focuses on improving the diagnosis and prognosis of breast cancer, particularly triple-negative breast cancer.

Latest Patents

One of Coqueret's latest patents is a method for in vitro diagnosing and prognosing the recurrence of triple-negative breast cancer. This invention is particularly important as it identifies specific biomarkers that are abnormally expressed in patients suffering from this aggressive form of cancer. These biomarkers are crucial for understanding the disease's aggressiveness and the patient's survival chances. Another significant patent involves olfactomedin-4, neudesin, and desmoplakin as biomarkers of breast cancer. This invention highlights the abnormal expression of these biomarkers in the blood of breast cancer patients, further aiding in the diagnosis of the disease.

Career Highlights

Throughout his career, Olivier Coqueret has worked with esteemed institutions such as the Institut de Cancérologie de l'Ouest and the Université d'Angers. His research has been pivotal in advancing the understanding of breast cancer and developing innovative diagnostic methods.

Collaborations

Coqueret has collaborated with notable colleagues, including Catherine Guette and Benjamin Barre. These partnerships have contributed to the success of his research and the development of his patents.

Conclusion

Olivier Coqueret's contributions to breast cancer management through his innovative patents demonstrate his commitment to improving patient outcomes. His work continues to influence the field and offers hope for better diagnostic methods in the future.